{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:43:48Z","timestamp":1792097028676,"version":"4.4.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,6,1]],"date-time":"2027-06-01T00:00:00Z","timestamp":1811808000000},"content-version":"am","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"NHLBI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Heart Failure"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jchf.2025.102899","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T04:49:45Z","timestamp":1768279785000},"page":"102899","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Implications of Potential Undiagnosed HFpEF on Symptomatic Response With Coronary Revascularization"],"prefix":"10.1016","volume":"14","author":[{"given":"Nicholas P.","family":"Bergeron","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander C.","family":"Egbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William R.","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv","family":"Gulati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan T.","family":"Demmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varun","family":"Sundaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry A.","family":"Borlaug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yogesh N.V.","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchf.2025.102899_bib1","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1007\/s12350-023-03375-4","article-title":"Increasing frequency of dyspnea among patients referred for cardiac stress testing","volume":"30","author":"Rozanski","year":"2023","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.jchf.2025.102899_bib2","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.amjcard.2013.10.019","article-title":"Meta-analysis of prognostic implications of dyspnea versus chest pain in patients referred for stress testing","volume":"113","author":"Argulian","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jchf.2025.102899_bib3","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1056\/NEJMoa2310610","article-title":"A placebo-controlled trial of percutaneous coronary intervention for stable angina","volume":"389","author":"Rajkumar","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2025.102899_bib4","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.117.003665","article-title":"Dyspnea among patients with chronic total occlusions undergoing percutaneous coronary intervention: prevalence and predictors of improvement","volume":"10","author":"Qintar","year":"2017","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jchf.2025.102899_bib5","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jacc.2018.04.039","article-title":"Myocardial injury and cardiac reserve in patients with heart failure and preserved ejection fraction","volume":"72","author":"Obokata","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2025.102899_bib6","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jacc.2017.05.029","article-title":"Arterial stiffening with exercise in patients with heart failure and preserved ejection fraction","volume":"70","author":"Reddy","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2025.102899_bib7","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1016\/j.jacc.2014.03.034","article-title":"Implications of coronary artery disease in heart failure with preserved ejection fraction","volume":"63","author":"Hwang","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2025.102899_bib8","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1161\/CIRCULATIONAHA.118.034646","article-title":"A simple, evidence-based approach to help guide diagnosis of heart failure with preserved ejection fraction","volume":"138","author":"Reddy","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2025.102899_bib9","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1001\/jamacardio.2022.1916","article-title":"Diagnosis of heart failure with preserved ejection fraction among patients with unexplained dyspnea","volume":"7","author":"Reddy","year":"2022","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jchf.2025.102899_bib10","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1161\/CIRCULATIONAHA.120.050304","article-title":"Initial invasive versus conservative management of stable ischemic heart disease in patients with a history of heart failure or left ventricular dysfunction: insights from the ISCHEMIA trial","volume":"142","author":"Lopes","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2025.102899_bib11","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1038\/s41591-024-03140-1","article-title":"An evidence-based screening tool for heart failure with preserved ejection fraction: the HFpEF-ABA score","volume":"30","author":"Reddy","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.jchf.2025.102899_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchf.2025.102526","article-title":"Utility of HFpEF diagnostic scores to stratify cardiac reserve among patients with dyspnea","volume":"13","author":"Ibe","year":"2025","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jchf.2025.102899_bib13","first-page":"1","article-title":"Cardiovascular survey methods","volume":"56","author":"Rose","year":"1968","journal-title":"Monogr Ser World Health Organ"},{"key":"10.1016\/j.jchf.2025.102899_bib14","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1161\/CIRCOUTCOMES.114.000967","article-title":"Development and validation of a short version of the Seattle Angina Questionnaire","volume":"7","author":"Chan","year":"2014","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jchf.2025.102899_bib15","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0735-1097(94)00397-9","article-title":"Development and evaluation of the Seattle Angina Questionnaire: a new functional status measure for coronary artery disease","volume":"25","author":"Spertus","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2025.102899_bib16","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1001\/jamacardio.2020.7478","article-title":"Interpretation of the Seattle Angina Questionnaire as an outcome measure in clinical trials and clinical care: a review","volume":"6","author":"Thomas","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jchf.2025.102899_bib17","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1161\/01.CIR.0000020688.24874.90","article-title":"Health status predicts long-term outcome in outpatients with coronary disease","volume":"106","author":"Spertus","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2025.102899_bib18","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ahj.2018.04.012","article-title":"Validation of the Seattle Angina Questionnaire in women with ischemic heart disease","volume":"201","author":"Patel","year":"2018","journal-title":"Am Heart J"},{"key":"10.1016\/j.jchf.2025.102899_bib19","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1161\/CIRCOUTCOMES.113.000752","article-title":"Comparison of the Seattle Angina Questionnaire with Daily Angina Diary in the TERISA clinical trial","volume":"7","author":"Arnold","year":"2014","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jchf.2025.102899_bib20","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","article-title":"EuroQoL--a new facility for the measurement of health-related quality of life","volume":"16","year":"1990","journal-title":"Health Policy"},{"key":"10.1016\/j.jchf.2025.102899_bib21","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1093\/eurheartj\/ehae345","article-title":"Loop diuretic therapy with or without heart failure: impact on prognosis","volume":"45","author":"Friday","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2025.102899_bib22","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1136\/heartjnl-2023-323577","article-title":"Outcomes in patients treated with loop diuretics without a diagnosis of heart failure: a retrospective cohort study","volume":"110","author":"Cuthbert","year":"2024","journal-title":"Heart"},{"key":"10.1016\/j.jchf.2025.102899_bib23","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/ejhf.1671","article-title":"Endothelium-dependent and independent coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction","volume":"22","author":"Yang","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2025.102899_bib24","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.1093\/eurheartj\/ehz713","article-title":"The haemodynamic basis of lung congestion during exercise in heart failure with preserved ejection fraction","volume":"40","author":"Reddy","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2025.102899_bib25","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.jchf.2018.03.003","article-title":"Hemodynamic correlates and diagnostic role of cardiopulmonary exercise testing in heart failure with preserved ejection fraction","volume":"6","author":"Reddy","year":"2018","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jchf.2025.102899_bib26","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1056\/NEJMoa042741","article-title":"Prognostic significance of dyspnea in patients referred for cardiac stress testing","volume":"353","author":"Abidov","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2025.102899_bib27","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1161\/CIRCHEARTFAILURE.109.930701","article-title":"Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction","volume":"3","author":"Borlaug","year":"2010","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2025.102899_bib28","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1093\/eurheartj\/ehy268","article-title":"Haemodynamics, dyspnoea, and pulmonary reserve in heart failure with preserved ejection fraction","volume":"39","author":"Obokata","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2025.102899_bib29","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/eurheartj\/ehaf027","article-title":"Dapagliflozin and ventilatory control during exercise in heart failure with preserved ejection fraction: the CAMEO-DAPA trial","volume":"46","author":"Doi","year":"2025","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2025.102899_bib30","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1093\/eurjhf\/hft026","article-title":"Cardiac output response to exercise in relation to metabolic demand in heart failure with preserved ejection fraction","volume":"15","author":"Abudiab","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2025.102899_bib31","first-page":"247","article-title":"Hemodynamics at rest and during exercise in 222 patients with coronary heart disease before and after aorto-coronary bypass surgery","volume":"62","author":"Roskamm","year":"1977","journal-title":"Cardiology"},{"key":"10.1016\/j.jchf.2025.102899_bib32","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/0002-9149(76)90105-3","article-title":"Effects of coronary artery bypass grafting on resting and exercise hemodynamics in patients with stable angina pectoris: a prospective, randomized study","volume":"37","author":"Barry","year":"1976","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jchf.2025.102899_bib33","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1161\/CIRCULATIONAHA.124.068788","article-title":"Dapagliflozin enhances arterial and venous compliance during exercise in heart failure with preserved ejection fraction: insights from the CAMEO-DAPA Trial","volume":"150","author":"Tada","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2025.102899_bib34","doi-asserted-by":"crossref","DOI":"10.1002\/clc.24158","article-title":"Antianginal effects of empagliflozin in patients with type 2 diabetes and refractory angina; a randomized, double-blind placebo-controlled trial (EMPT-ANGINA trial)","volume":"47","author":"Mansouri","year":"2024","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jchf.2025.102899_bib35","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/s41591-024-03374-z","article-title":"Effects of tirzepatide on circulatory overload and end-organ damage in heart failure with preserved ejection fraction and obesity: a secondary analysis of the SUMMIT trial","volume":"31","author":"Borlaug","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/j.jchf.2025.102899_bib36","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.jchf.2019.04.019","article-title":"Hemodynamic effects of weight loss in obesity: a systematic review and meta-analysis","volume":"7","author":"Reddy","year":"2019","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jchf.2025.102899_bib37","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","article-title":"Semaglutide and cardiovascular outcomes in obesity without diabetes","volume":"389","author":"Lincoff","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2025.102899_bib38","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/j.mayocp.2025.07.009","article-title":"Estimating the burden of undiagnosed heart failure with preserved ejection fraction and sleep abnormalities in the community","volume":"100","author":"Reddy","year":"2025","journal-title":"Mayo Clin Proc"}],"container-title":["JACC: Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177925008297?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177925008297?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:43:55Z","timestamp":1792093435000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213177925008297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2213177925008297"],"URL":"https:\/\/doi.org\/10.1016\/j.jchf.2025.102899","relation":{},"ISSN":["2213-1779"],"issn-type":[{"value":"2213-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Implications of Potential Undiagnosed HFpEF on Symptomatic Response With Coronary Revascularization","name":"articletitle","label":"Article Title"},{"value":"JACC: Heart Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchf.2025.102899","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}],"article-number":"102899"}}